Therapeutic Asset Ratings
502 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Trastuzumab Deruxtecan
Carcinoma Of Pharynx
AstraZeneca
D
(30)
Trastuzumab Deruxtecan
Thyroid Cancer
AstraZeneca
D
(30)
Trastuzumab Deruxtecan
Carcinoma Of Urethra
AstraZeneca
D
(30)
Trastuzumab Deruxtecan
Vaginal Cancer
AstraZeneca
D
(30)
Trastuzumab Deruxtecan
Vulva Cancer
AstraZeneca
D
(30)
azd0754
Hepatocellular Carcinoma
AstraZeneca
D
(28)
Trastuzumab Deruxtecan
Cervical Cancer
AstraZeneca
D
(28)
Trastuzumab Deruxtecan
Esophageal Cancer
AstraZeneca
D
(28)
Trastuzumab Deruxtecan
Liver Cancer
AstraZeneca
D
(28)
Trastuzumab Deruxtecan
Melanoma
AstraZeneca
D
(28)
Trastuzumab Deruxtecan
Small Cell Lung Carcinoma
AstraZeneca
D
(28)
azd0754
Prostate Cancer
AstraZeneca
D
(26)
azd5851
Prostate Cancer
AstraZeneca
D
(26)
Exenatide
Pancreatic Neoplasm
AstraZeneca
D
(26)
Trastuzumab Deruxtecan
Pancreatic Neoplasm
AstraZeneca
D
(26)
azd6234
Type 2 Diabetes Mellitus
AstraZeneca
P2
NR
(0)
azd6234
Endocrine System Disorder
AstraZeneca
P2
NR
(0)
Volrustomig
Cervical Cancer
AstraZeneca
P2
NR
(0)
Volrustomig
Head And Neck Squamous Cell Carcinoma
AstraZeneca
P2
NR
(0)
Volrustomig
Esophageal Squamous Cell Carcinoma
AstraZeneca
P2
NR
(0)
Volrustomig
Malignant Pleural Mesothelioma
AstraZeneca
P2
NR
(0)
azd1390
Neoplastic Meningitis
AstraZeneca
P1
NR
(0)
azd9592
Non-Small Cell Lung Carcinoma
AstraZeneca
P1
NR
(0)
Opemalirsen
Kidney Failure
AstraZeneca
P1
NR
(0)
Sabestomig
Classic Hodgkin Lymphoma
AstraZeneca
P1
NR
(0)
Showing 476 to 500 of 502 assets
Previous
Page 20 of 21
Next
